RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.
LeaveRussia detail: Continue Operations
Recordati Industria Chimica e Farmaceutica S.p.A., doing business as Recordati SpA, manufactures pharmaceuticals. The Company researches, develops, manufactures, and markets prescription and non-prescription pharmaceuticals, pharmaceutical chemicals, therapeutic products, and rare disease treatments. The Company sells its products throughout the world.
Business in Russia
Russia had an exceptionally busy season for coughs and colds, with sales there up 40% in the 1Q2023. Russia, Ukraine and other CIS countries accounted for just over 7% of annual sales last year, according to the company’s annual report.
Decision trail
Decision date 11/05/2023 · Reference ↗
Italy's Recordati boosted by strong sales in Russia. Italian drug maker Recordati benefited from strong demand in markets such as Turkey and Russia in the first three months of the year, its chief executive said on May 11, 2023 after the company lifted its annual revenue and profit targets. Koremans said that Recordati did not produce any products in Russia but continued to import treatments for rare diseases, as well as prescription drugs for more routine conditions.
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional